The Medicare
conference agreement fails the two critical requirements of a
responsible drug benefit program for the nation's seniors. The
original idea underlying this legislation was never just about
adding drug coverage to Medicare. It was about doing so in a way
that would not lead to huge additional liabilities to future
generations, and in a way that would reform the program so that it
could respond to the changing needs of the elderly and disabled. But the agreement will
not lead to that. Instead it guts critical reforms, relegating them
to a "demonstration project" that is doomed to failure. And it
opens the floodgates to new entitlement spending that will mean
huge taxes on future workers.
It is time for
Congress and the President to go back to the drawing board and
do two things:
-
Congress should
enact a limited measure, based on the discount card agreed to by
the conference that will actually help most seniors who now lack
affordable drug coverage.
-
The President
and Members of Congress committed to reform must do what they
failed to do effectively over the last two years - methodically
build the case with the American people for critical reforms in the
program. Changes in sensitive programs like Medicare can only be
achieved through a public campaign, not through back-door
deals.
What's
Wrong With the Conference Agreement
Early text from
Medicare conferees indicate critical decisions have been made that
should cause great concern to reformers and to taxpayers. Among
them:
-
The agreement
means explosive new costs and huge unfunded liabilities that will
burden future generations. In less than a month after the House
and Senate passage of the Medicare drug provisions, the
Congressional Budget Office revised the projected ten-year costs
upwards from $400 billion to $425 billion and $432 billion,
respectively.
But this is just the tip of the iceberg. Of far greater concern is
the staggering increase in the unfunded liabilities of an already
insolvent Medicare program. The projected unfunded liability of the
Medicare drug proposal, for current Medicare beneficiaries alone,
is estimated at $2.6 trillion.
The projected drug
costs will build pressure to repeal the Bush tax cuts
and significantly
increase the tax burdens on working families and future
generations.
Instead of adopting a financing mechanism similar to the FEHBP,
which would impose a cap on the dollar amount of the government
contribution to health plans, the conferees have instead proposed a
process for the President and the House and Senate to address
formally the future demands on the general revenues required to
finance the Medicare program.
.
The unintended consequence of patient dumping discussed below will
incur even higher federal costs with tens of billions of dollars in
federal subsidies to profitable corporations in an attempt to
discourage them from dumping millions of retirees out of their
private coverage. Thus, taxpayers will be forced to bear the high
price to prevent a massive disruption of the private coverage
aggravated by the incentives in the Medicare bill. It makes no
difference whether this disruption is intentional, carefully
engineered or merely the product of a major congressional
miscalculation.
-
The agreement
guts the House bill's "premium support" provision in favor of a
limited and doomed demonstration program. The heart of real
Medicare reform is premium support financing structure and a
competitive system modeled after Congress' own health system, the
Federal Employees Health Benefits Program (FEHBP). This was the key
component of the majority (Breaux-Thomas) recommendations of the
National Bipartisan Commission on The Future of Medicare in 1999,
and an original model of reform for the Bush Administration. The
House bill had provided that Medicare would move toward such a
system beginning in 2010. Senator Edward Kennedy (D-MA), among
others, has been adamantly opposed to the creation of a consumer-
based system, even for the next generation of seniors.
The agreement ends the prospect of real reform in favor of a
"demonstration project" for Medicare reform in six metropolitan
areas - and even that is not scheduled to begin for seven years.
But the demonstration proposal is a retreat from the structural
changes that are necessary for the future of the Medicare program.
Like its predecessors, such a "demonstration" is almost bound to
fail; various providers who wanted to be insulated from both price
competition and congressional micro-management or obstruction have
deliberately undermined previous Medicare demonstration projects.
-
The agreement
contains an unworkable and potentially unpopular drug benefit, with
millions of Americans losing part of their existing coverage.
Instead of targeting benefits to seniors who need them, the
Medicare conferees are insisting on creating a universal drug
entitlement to be delivered through the vehicle of stand-alone
insurance. Indeed, media is reporting that conferees are going to
make the government drug benefit less onerous to Medicare
beneficiaries, by increasing taxpayer obligations even more.
In the process,
according to both Congressional Budget Office and recent
independent economic analysis,
more than 4 million
seniors with existing private coverage are bound to lose it or have
it scaled back.
Meanwhile, the politically engineered premiums and deductibles,
coupled with their odd combination of "doughnut holes" or gaps in
drug coverage, are likely to be unpopular with seniors. The
proposed government drug benefits are clearly inferior to existing
employer-based coverage. Not surprisingly, surveys show that most
seniors, when the drug provisions are explained to them, don't like
them.
-
The conferees
have agreed to a "fallback position" on the provision of
prescription drugs that will further undermine private plans.
It is questionable whether the insurance options would even
materialize in sufficient numbers under the agreement, leaving the
drug benefit itself to be delivered under some version of a
"fall-back" provision run by the government.
The fallback means
that the federal government would assume responsibility for the
provision of prescription drugs in any region of the country where
there is an insufficient number of private plans.
Under the conference
agreement, a government fallback program would be operational if
beneficiaries do not have access to at least one stand alone
prescription drug plan and one integrated health plan in each
region; two drug only plans must be available if no integrated plan
is available in any given region.
It is worth noting that the Bush Administration initially denounced
the Senate fallback provision because it would discourage private
plans from entering the market in the first place, and would lead
to government control of the delivery and pricing of prescription
drugs.
White House officials correctly argued that the fall back provision
would discourage private entities from bearing the insurance risk
for prescription coverage. This could lead to direct government
control over the financing and delivery of most prescription drugs
in the United States.
-
The conferees
commit Congress to spending tens of billions in federal subsidies
and create special tax breaks for corporations to make the
universal drug entitlement politically palatable, and thus expand
direct federal control over corporate health benefit practices.
The creation of a universal government entitlement for drug
coverage would create a powerful incentive for companies to dump
retirees out of their existing coverage into the government drug
program, or at least to scale back their existing coverage. The
Congressional Budget Office (CBO), as well as independent health
policy analysts, has indicated that roughly one out of every three
retirees with employer- based coverage would lose it. To offset
these incentives, the House and Senate conferees have agreed to
special federal subsidies to corporations to discourage them from
dumping retiree drug coverage, estimated at more than $70 billion
over ten years.
Moreover, the provision of such taxpayer funding as a condition for
the continuation of employer- based drug coverage will open up a
new avenue of federal control over private sector benefit
setting.
-
Cramping
private health plan competition. Both the House and Senate
bills attempt to create new competitive options for private health
insurance, but these are marred by regulatory excesses that will
surely limit personal choice and free market competition.
Particularly onerous are the comprehensive standardization of
health benefits for private health plans and the imposition of a
straight-jacketed system of geographical service areas.
An Interim
Proposal
It is time for Washington to recognize that the current
process of developing a drug benefit with Medicare reform was
ill-fated from the start. Once it was clear to Capitol Hill that
the President was not going to build on his initial set of
principles by taking the high-profile lead to build public and
congressional support in addressing the tough issues, it became
increasingly difficult for serious reformers in Congress to achieve
a responsible outcome. Those fundamental issues, such as how to
deal with the staggering liabilities of Medicare that threaten the
program's ability to deliver existing benefits, remain unresolved
as Congress seems poised to add to the burden on future
generations.
Faced with the
prospect of political and policy failure, Congress and the
President should change course and focus on two objectives in the
remaining weeks of this session. First, Congress should put
off creating a major new drug benefit and instead enact a modest
program focused on those genuinely in need. Second, the
President should reassemble a "coalition of the willing" of those
members of congress from both parties who are prepared to change
the Medicare program for the next generation of retirees, the baby
boom generation. . Working closely with
this coalition - consisting of congressional leaders who are
committed to responsible reform-, the President should embark on a
national campaign to discuss the key reform issues in Medicare and
to build public support for major reform legislation.
Specifically, with
the active support of the President, Congress should:
The conferees have
already adopted a prescription drug card, and they are in agreement
on the need to subsidize the coverage of low-income seniors. The
provision would enable all seniors to have a choice between at
least two different drug cards that would secure drug discounts
between 15 percent and 25 percent. Low-income seniors would also be
able to get a $600 annual subsidy to cover the cost of their
prescriptions.
Congress also may
wish to add a provision for government-subsidized private
catastrophic coverage to protect poor seniors against high drug
costs. This could be done immediately, and the access problem
facing poor seniors without prescription drug coverage could be
resolved quickly and efficiently.
-
The President should
embark upon a major public information campaign to explain to
Americans why the Medicare program should be changed for the Baby
Boomers who start in retiring in huge numbers, beginning in 2010.
He should work directly with willing members of Congress, in either
party, who are committed to real reform of the program. Together,
they should develop and enact a coherent and responsible Medicare
reform plan.
In 1997, with the strong support of
President Bill Clinton, Congress created the National Bipartisan
Commission on the Future of Medicare. This, among other major
Medicare provisions, was a significant advance in public policy
under the Balanced Budget Act of 1997. Chaired by Senator John
Breaux (D-LA) and Representative Bill Thomas (R-CA), the commission
completed 18 months of hearings, briefings, studies, and analyses
on the Medicare program and its future. A majority of the
commission reached a consensus and voted in 1999 to recommend
changes in the program that would transform it into a superior
system like the popular and successful Federal Employees Health
Benefits Program. President Clinton failed to build upon the work
of the Commission, and an historic opportunity to make change was
lost.
President Bush
does not have to repeat this disastrous mistake. But to avoid it,
he must be directly engaged. To fashion a coherent policy and build
strong public support to advance the reform agenda on Capitol Hill,
the President must work closely with congressional reformers who
are sincerely committed to the necessary structural reform.
Together, they could develop and present a detailed, market-based
reform program to Congress for enactment as soon as possible. With
congressional and executive branch cooperation on a shared goal of
real Medicare reform, lawmakers should be able to move very
quickly, building upon the solid policy work and first-rate
analyses produced in 1999 by the Bipartisan Commission and its
staff. Meanwhile, President Bush should commit to building public
support for the reform measure.
A critical element
to achieve success is that the President must commit himself to
building public support for real Medicare reform , so that his
recommendations will command wide support when presented to
Congress.
Consequences of
Failure
The President must
make a strong and sustained case for change. The Congress has an
historic opportunity to prepare the Medicare program for the baby
boomers-the next generation of senior citizens. They will be
retiring in just eight years. The consequences of failure are
unacceptable, both for future retirees and for the future
generations of taxpayers who will be supporting them. It is wrong
for Congress to deny an entire generation the right to choose their
own health care plans, especially when medical and information
technology are rapidly evolving and opening up unprecedented
opportunities to serve the personal needs of millions of
Americans.
The broader
structural reform of Medicare should continue. It should not be
reduced to another failed demonstration program, or otherwise
watered down and rendered ineffectual. But it should be done
carefully and with the full support of the President in his
capacity as the nation's leader. It is unlikely that solid Medicare
reform will be accomplished without a clean and coherent set of
reform proposals forged by a willing coalition of Members committed
to real reform, a reliance on the solid work done by the previous
Bipartisan Commission, or the President making a strong public case
for change and weighing in on the specifics of Medicare reform
policy.
Meanwhile,
Congress can and should, quickly and efficiently, resolve the
problem for seniors without drug coverage. They can do that
immediately, and they should.
Stuart M.
Butler, Ph.D., is Vice President for Domestic
and Economic Policy Studies atThe Heritage
Foundation, and Robert E. Moffit,
Ph.D., is Director of the Center
for Health Policy Studies at The Heritage
Foundation.